Christopher T. Cummings

1.9k total citations
28 papers, 1.4k citations indexed

About

Christopher T. Cummings is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Christopher T. Cummings has authored 28 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Immunology, 11 papers in Molecular Biology and 7 papers in Oncology. Recurrent topics in Christopher T. Cummings's work include Phagocytosis and Immune Regulation (12 papers), Pancreatic and Hepatic Oncology Research (5 papers) and Cancer Mechanisms and Therapy (4 papers). Christopher T. Cummings is often cited by papers focused on Phagocytosis and Immune Regulation (12 papers), Pancreatic and Hepatic Oncology Research (5 papers) and Cancer Mechanisms and Therapy (4 papers). Christopher T. Cummings collaborates with scholars based in United States, Spain and Hong Kong. Christopher T. Cummings's co-authors include Douglas K. Graham, Michael J. Morgan, Andrew Thorburn, Jacqueline Thorburn, Paola Maycotte, Deborah DeRyckere, Suraj Aryal, H. Shelton Earp, Lynn E. Heasley and Susan Sather and has published in prestigious journals such as Nucleic Acids Research, PLoS ONE and Cancer Research.

In The Last Decade

Christopher T. Cummings

26 papers receiving 1.4k citations

Peers

Christopher T. Cummings
Suprit Gupta United States
Brian C. Grabiner United States
Shinichi Yabuuchi Japan
Ming Lü China
Annan Yang United States
Pjotr Knyazev Germany
Ling Cen United States
Jiang‐Sha Zhao China
Kirill V. Rosen Canada
Nilgun Tasdemir United States
Suprit Gupta United States
Christopher T. Cummings
Citations per year, relative to Christopher T. Cummings Christopher T. Cummings (= 1×) peers Suprit Gupta

Countries citing papers authored by Christopher T. Cummings

Since Specialization
Citations

This map shows the geographic impact of Christopher T. Cummings's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher T. Cummings with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher T. Cummings more than expected).

Fields of papers citing papers by Christopher T. Cummings

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher T. Cummings. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher T. Cummings. The network helps show where Christopher T. Cummings may publish in the future.

Co-authorship network of co-authors of Christopher T. Cummings

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher T. Cummings. A scholar is included among the top collaborators of Christopher T. Cummings based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher T. Cummings. Christopher T. Cummings is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Puerto, Marta, Mònica Torras‐Llort, Carme Solé, et al.. (2024). The zinc-finger protein Z4 cooperates with condensin II to regulate somatic chromosome pairing and 3D chromatin organization. Nucleic Acids Research. 52(10). 5596–5609. 3 indexed citations
2.
Cummings, Christopher T., et al.. (2024). The chromatin tapestry as a framework for neurodevelopment. Genome Research. 34(10). 1477–1486.
3.
Cummings, Christopher T. & Lois J. Starr. (2022). Biallelic GTF2IRD1 variants in brothers with profound neurodevelopmental disorder: A possible novel disorder involving a critical gene for Williams syndrome. American Journal of Medical Genetics Part A. 191(2). 332–337. 1 indexed citations
4.
Cummings, Christopher T. & M. Jordan Rowley. (2022). Implications of Dosage Deficiencies in CTCF and Cohesin on Genome Organization, Gene Expression, and Human Neurodevelopment. Genes. 13(4). 583–583. 10 indexed citations
5.
Cummings, Christopher T., et al.. (2021). Evaluation of Risk Factors and Approach to Screening for Asymptomatic Neonatal Hypoglycemia. Neonatology. 119(1). 77–83. 4 indexed citations
6.
Lee, Minjung, Trevor Glaros, Weihe Zhang, et al.. (2020). UNC2025 , a Potent and Orally Bioavailable MER/FLT3 Dual Inhibitor. Figshare. 6 indexed citations
7.
Kazi, Aslamuzzaman, Shengyan Xiang, Hua Yang, et al.. (2019). Dual Farnesyl and Geranylgeranyl Transferase Inhibitor Thwarts Mutant KRAS-Driven Patient-Derived Pancreatic Tumors. Clinical Cancer Research. 25(19). 5984–5996. 53 indexed citations
8.
Cummings, Christopher T., Mari Iida, Rebecca E. Parker, et al.. (2018). MERTK Mediates Intrinsic and Adaptive Resistance to AXL-targeting Agents. Molecular Cancer Therapeutics. 17(11). 2297–2308. 41 indexed citations
9.
Cummings, Christopher T., Weihe Zhang, Kurtis D. Davies, et al.. (2015). Small Molecule Inhibition of MERTK Is Efficacious in Non–Small Cell Lung Cancer Models Independent of Driver Oncogene Status. Molecular Cancer Therapeutics. 14(9). 2014–2022. 50 indexed citations
10.
Morgan, Michael J., Graciela Gamez, Jacqueline Thorburn, et al.. (2014). Regulation of autophagy and chloroquine sensitivity by oncogenic RAS in vitro is context-dependent. Autophagy. 10(10). 1814–1826. 80 indexed citations
11.
DeRyckere, Deborah, Amanda A. Hill, Xiaodong Wang, et al.. (2014). Abstract 1740: Development of a novel small molecule MER tyrosine kinase inhibitor with therapeutic activity in cell culture and mouse models of acute lymphoblastic leukemia. Cancer Research. 74(19_Supplement). 1740–1740. 2 indexed citations
12.
Zhang, Weihe, Deborah DeRyckere, Debra M. Hunter, et al.. (2014). UNC2025, a Potent and Orally Bioavailable MER/FLT3 Dual Inhibitor. Journal of Medicinal Chemistry. 57(16). 7031–7041. 118 indexed citations
13.
Liu, Jing, Weihe Zhang, Michael A. Stashko, et al.. (2013). UNC1062, a new and potent Mer inhibitor. European Journal of Medicinal Chemistry. 65. 83–93. 55 indexed citations
14.
Hinz, Trista K., Emily K. Kleczko, Katherine R. Singleton, et al.. (2013). A mechanism of resistance to gefitinib mediated by cellular reprogramming and the acquisition of an FGF2-FGFR1 autocrine growth loop. Oncogenesis. 2(3). e39–e39. 203 indexed citations
15.
Zhang, Weihe, Dehui� Zhang, Michael A. Stashko, et al.. (2013). Pseudo-Cyclization through Intramolecular Hydrogen Bond Enables Discovery of Pyridine Substituted Pyrimidines as New Mer Kinase Inhibitors. Journal of Medicinal Chemistry. 56(23). 9683–9692. 55 indexed citations
16.
Linger, Rachel M.A., Richard A. Cohen, Christopher T. Cummings, et al.. (2012). Mer or Axl receptor tyrosine kinase inhibition promotes apoptosis, blocks growth and enhances chemosensitivity of human non-small cell lung cancer. Oncogene. 32(29). 3420–3431. 170 indexed citations
17.
Maycotte, Paola, Suraj Aryal, Christopher T. Cummings, et al.. (2012). Chloroquine sensitizes breast cancer cells to chemotherapy independent of autophagy. Autophagy. 8(2). 200–212. 338 indexed citations
18.
Cummings, Christopher T., et al.. (2012). Synthesis of cyclopropyl glycosides and their use as novel glycosyl donors. Carbohydrate Research. 356. 288–294. 1 indexed citations
19.
Zhong, Yi, Zheng Wang, Baojin Fu, et al.. (2011). GATA6 Activates Wnt Signaling in Pancreatic Cancer by Negatively Regulating the Wnt Antagonist Dickkopf-1. PLoS ONE. 6(7). e22129–e22129. 81 indexed citations
20.
Karafin, Matthew S., Christopher T. Cummings, Baojin Fu, & Christine A. Iacobuzio–Donahue. (2009). The developmental transcription factor Gata4 is overexpressed in pancreatic ductal adenocarcinoma.. PubMed. 3(1). 47–55. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Suprit Gupta Breakdown of academic impact, for papers by Brian C. Grabiner Breakdown of academic impact, for papers by Shinichi Yabuuchi Breakdown of academic impact, for papers by Ming Lü Breakdown of academic impact, for papers by Annan Yang Breakdown of academic impact, for papers by Pjotr Knyazev Breakdown of academic impact, for papers by Ling Cen Breakdown of academic impact, for papers by Jiang‐Sha Zhao Breakdown of academic impact, for papers by Kirill V. Rosen Breakdown of academic impact, for papers by Nilgun Tasdemir
Rankless by CCL
2026